Hemp Biz Group Urges FDA Action On CBD After New Study
By Sarah Jarvis (May 18, 2022, 10:10 PM EDT) -- The U.S. Hemp Roundtable has again urged the U.S. Food and Drug Administration to begin regulating CBD and other hemp derivatives, pointing to a recently released study it says confirms the safety of orally ingested CBD and addresses the FDA's concerns.
The trade association said Tuesday that the results of a study conducted by Validcare LLC and completed in March indicate that daily consumption of typical retail CBD products "is not associated with elevated liver tests, low testosterone levels, or daytime drowsiness."
Jonathan Miller, the Roundtable's general counsel, said in a statement that the "real-world data" the FDA has been soliciting...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!